Lazard Asset Management’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-34
Closed 2583
2025
Q1
$0 Sell
34
-99
-74% -$1.76K ﹤0.01% 2624
2024
Q4
$2K Sell
133
-33,145
-100% -$448K ﹤0.01% 2197
2024
Q3
$383K Buy
33,278
+16,550
+99% +$190K ﹤0.01% 1439
2024
Q2
$189K Buy
16,728
+9,035
+117% +$120K ﹤0.01% 1577
2024
Q1
$110K Sell
7,693
-374
-5% -$5.3K ﹤0.01% 1506
2023
Q4
$110K Buy
+8,067
New +$85K ﹤0.01% 1622
2023
Q2
Sell
-7,977
Closed -$63K 2581
2023
Q1
$63K Buy
7,977
+5,174
+185% +$53.2K ﹤0.01% 1725
2022
Q4
$31K Buy
+2,803
New +$30.6K ﹤0.01% 2013

Lazard Asset Management's PTVE Position: Q2 2025 in Review

Lazard Asset Management sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 34 shares.

Lazard Asset Management first reported a position in PTVE in Q4 2022 and held it in 8 quarters. The position peaked at $383K in Q3 2024. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.

  • Lazard Asset Management reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
  • Lazard Asset Management sold 34 Pactiv Evergreen Inc. Common stock shares in Q2 2025.
  • Lazard Asset Management first reported a position in Pactiv Evergreen Inc. Common stock in Q4 2022 and held it in 8 quarters.
  • Lazard Asset Management's Pactiv Evergreen Inc. Common stock position peaked at $383K in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.

Based on Lazard Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.